-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $16

Benzinga·06/30/2026 13:21:41
Listen to the news
Jones Trading analyst Debanjana Chatterjee initiates coverage on Alterity Therapeutics (NASDAQ:ATHE) with a Buy rating and announces Price Target of $16.